Proactive will host a Lifesciences Webinar on Tuesday, August 10, with three ASX-listed companies – Noxopharm Ltd (ASX:NOX), Global Health Ltd (ASX:GLH) and Compumedics Ltd (ASX:CMP) — set to present on upcoming plans and strategies for the remainder of 2021.
Each company will present for 12 minutes, followed by a 5-minute Q&A session, which will be live-streamed on the Proactive YouTube channel, where it can be viewed at any time following the event.
Click here to register.
Questions for the speakers can be submitted before and during the online presentations by email to John Phillips at john.phillips@proactiveinvestors.com or by text to 0431 597 771.
Noxopharm
First to take the stage is Noxopharm managing director Graham Kelly, who will outline the company’s latest achievements, including the Notice of Allowance on its key Veyonda® patent from the European Patent Office.
The clinical-stage drug development company, with headquarters in New South Wales, is developing the first-in-class, dual-acting cytotoxic and immuno-oncology Veyonda® drug candidate, designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy.
Noxopharm worked across its four development programs over FY21’s final quarter, with activity across its clinical oncology, cancer research, septic shock and chronic inflammatory and autoimmune diseases portfolios.
Global Health
Next in line is Global Health executive director Mathew Cherian.
The company is a leading provider of digital health solutions to the Australian healthcare industry.
Its applications help streamline the delivery of healthcare services to provide better health outcomes for people living with chronic conditions such as mental health illness, diabetes, and cardiovascular disease.
Compumedics
To conclude the webinar, Compumedics chief executive officer David Burton will provide investors with a summary of its business activities for the June quarter.
Established in 1987, the global technology leader has so far focused on the fast growing, high value sleep medicine market.
It is also now focusing on the associated fields of neuro-diagnostics and brain research.
Event details
When: Tuesday, August 10, 2021
Time: 12:00 pm Sydney time/ 10:00 am Perth time
Focus: Lifesciences webinar
Register here: https://event.webinarjam.com/register/82/6k43xh7w